Ictammolo Afom

Ichthammol, the active ingredient in Ictammolo Afom, is a topical anti‑inflammatory presented as a skin‑application preparation for external use. It is employed to soothe inflamed, infected or keratinised skin lesions and is suitable for adult and pediatric patients as directed by a healthcare professional.

GNH USA supplies Ictammolo Afom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ictammolo Afom is a topical anti‑inflammatory that acts on various dermatologic conditions.

Dermatitis: reduces inflammation and promotes healing of affected skin. Eczema: alleviates itching and redness while supporting skin barrier recovery. Acne: softens keratin plugs and limits bacterial growth to improve lesions. Boils: facilitates drainage and diminishes surrounding inflammation. Insect bites: calms local swelling and prevents secondary infection. Minor skin infections: provides antibacterial action to aid resolution of superficial infections.

Topical application of Ictammolo Afom may be associated with skin‑related adverse reactions.

Common Side Effects: - Mild skin irritation or burning sensation. - Local dryness or peeling. - Transient erythema at the application site. - Itching or pruritus. - Allergic contact dermatitis. - Slight stinging on broken skin.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) requiring immediate medical attention. - Extensive skin necrosis or ulceration. - Systemic toxicity from excessive absorption (very rare). - Persistent swelling or bullae formation. - Secondary infection due to compromised skin barrier. - Unexplained systemic hypersensitivity symptoms.

Before using Ictammolo Afom, consider the following safety measures.

Avoid application on broken skin: limit use to intact lesions. Do not use on large body areas: restrict to small affected zones. Discontinue if irritation occurs: monitor skin response and stop use if worsening. Consult a healthcare professional before use in children: pediatric safety has not been fully established. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ictammolo Afom may interact with other topical agents; review the following considerations.

Major Interactions (Avoid): - Concurrent use with other topical antibiotics: may increase risk of local irritation. - Application under occlusive dressings: can enhance systemic absorption and cause toxicity. - Combination with strong keratolytics (e.g., high‑strength salicylic acid): may cause excessive skin peeling.

Moderate Interactions (Monitor Closely): - Use with topical corticosteroids: may alter anti‑inflammatory efficacy; monitor therapeutic response. - Simultaneous phototherapy: potential for increased photosensitivity. - Co‑application with other keratolytic agents: watch for over‑desquamation and skin barrier disruption.